LL Capital Corp. Announces TSXV Conditional Approval, SEDAR Filing of Filing Statement and Further Details on the Proposed Acquisition of Syncordia Technologies and Healthcare Solutions, Inc.

TORONTO, ONTARIO--(Marketwired - June 25, 2015) - LL Capital Corp. (the "Corporation") (TSX VENTURE:LLA.P) is pleased to announce that it has received conditional approval from the TSX Venture Exchange (the "TSXV") relating to its previously announced proposed qualifying transaction (the "Proposed Transaction") with Syncordia Technologies and Healthcare Solutions, Inc. ("Syncordia"). The Proposed Transaction is currently scheduled to close on or about June 29, 2015. A filing statement prepared in accordance with the requirements of the TSXV in connection with the Proposed Transaction has been filed with the TSXV and the applicable Canadian securities regulators on SEDAR and is available at www.sedar.com.

For additional information about the Proposed Transaction, please see the Corporation's press releases dated April 13, 2015 and June 12, 2015, respectively, which are available at www.sedar.com.

ABOUT SYNCORDIA

Syncordia has operations in North America and Europe, and is focused on investing in, partnering with and growing revenue cycle management ("RCM") companies where proprietary technology can be used as an accelerator. Syncordia addresses a great void in niche healthcare sectors, such as EMS and behavioral health, where the necessary workflow/production/analytic components are largely absent or inadequate for a RCM company to maintain quality with scale. Syncordia is actively acquiring medical billing companies and is building a proprietary suite of RCM software solutions called the Syncordia Cloud, which includes patient scheduling, electronic health records, claims management, analytics and more. Syncordia's ability to not only offer but control the entire product offering of both software and solutions uniquely positions the company to be able to deliver a refreshingly simple and powerful product offering that's largely absent in healthcare today. Led by a team of executives with extensive experience in RCM and technology, acquisition opportunities are carefully selected to become part of the Syncordia family and enable Syncordia's vision of becoming a world class technology enhanced RCM Company with best in class solutions.